The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Heat Shock Proteins and Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3
Thuringer, D., Jégo, G., Wettstein, G., Terrier, O., Cronier, L., Yousfi, N., Hébrard, S., Bouchot, A., Hazoumé, A., Joly, A.-L., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-226977 · Cited by 122
RetractedHSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Heat shock factors: integrators of cell stress, development and lifespan
Åkerfelt, M., Morimoto, R. I., & Sistonen, L. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2938 · Cited by 1,455
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
Ciocca, D. R., & Calderwood, S. K. (2005) · Cell Stress & Chaperones · doi:10.1379/csc-99r.1 · Cited by 1,404
Guidelines for the nomenclature of the human heat shock proteins
Kampinga, H. H., Hageman, J., Vos, M. J., Kubota, H., Tanguay, R. M., Bruford, E. A., Cheetham, M. E., Chen, B., & Hightower, L. E. (2009) · Cell Stress and Chaperones · doi:10.1007/s12192-008-0068-7 · Cited by 1,360
Structure and mechanism of the Hsp90 molecular chaperone machinery
Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103
Hsp27 negatively regulates cell death by interacting with cytochrome c
Bruey, J.-M., Ducasse, C., Bonniaud, P., Ravagnan, L., Susin, S. A., Diaz-Latoud, C., Gurbuxani, S., Arrigo, A.-P., Kroemer, G., Solary, E., et al. (2000) · Nature Cell Biology · doi:10.1038/35023595 · Cited by 985
Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27
Freshney, N. W., Rawlinson, L., Guesdon, F., Jones, E., Cowley, S., Hsuan, J., & Saklatvala, J. (1994) · Cell · doi:10.1016/0092-8674(94)90278-x · Cited by 864
GRP78 Induction in Cancer: Therapeutic and Prognostic Implications
Lee, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0325 · Cited by 856
The role of the unfolded protein response in tumour development: friend or foe?
Ma, Y., & Hendershot, L. M. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1505 · Cited by 710
Reddy, R. K., Mao, C., Baumeister, P., Austin, R. C., Kaufman, R. J., & Lee, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212328200 · Cited by 695
STRUCTURE AND FUNCTION IN GroEL-MEDIATED PROTEIN FOLDING
Sigler, P. B., Xu, Z., Rye, H. S., Burston, S. G., Fenton, W. A., & Horwich, A. L. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.581 · Cited by 572
Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization
Nylandsted, J., Gyrd-Hansen, M., Danielewicz, A., Fehrenbacher, N., Lademann, U., Høyer-Hansen, M., Weber, E., Multhoff, G., Rohde, M., & Jäättelä, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040531 · Cited by 545
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Marcu, M. G., Chadli, A., Bouhouche, I., Catelli, M., & Neckers, L. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003701200 · Cited by 502
Murphy, M. E. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt111 · Cited by 502
Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
Ma, X.-H., Piao, S.-F., Dey, S., Mcafee, Q., Karakousis, G., Villanueva, J., Hart, L. S., Levi, S., Hu, J., Zhang, G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70454 · Cited by 457
Li, J., Ni, M., Lee, B., Barron, E., Hinton, D. R., & Lee, A. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.81 · Cited by 452
Lv, L.-H., Wan, Y.-L., Lin, Y., Zhang, W., Yang, M., Li, G.-L., Lin, H.-M., Shang, C.-Z., Chen, Y.-J., & Min, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340588 · Cited by 420
Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity.
Jäättelä, M., Wissing, D., Bauer, P. A., & Li, G. C. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05433.x · Cited by 363
Sequist, L. V., Gettinger, S., Senzer, N. N., Martins, R. G., Jänne, P. A., Lilenbaum, R., Gray, J. E., Iafrate, A. J., Katayama, R., Hafeez, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.8338 · Cited by 330
Withaferin A targets heat shock protein 90 in pancreatic cancer cells
Yu, Y., Hamza, A., Zhang, T., Gu, M., Zou, P., Newman, B., Li, Y., Gunatilaka, A. A. L., Zhan, C.-G., & Sun, D. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.017 · Cited by 316
Caldas-Lopes, E., Cerchietti, L., Ahn, J. H., Clement, C. C., Robles, A. I., Rodina, A., Moulick, K., Taldone, T., Gozman, A., Guo, Y., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903392106 · Cited by 315
Hsp60 Regulation of Tumor Cell Apoptosis
Ghosh, J. C., Dohi, T., Kang, B. H., & Altieri, D. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705904200 · Cited by 310
Fu, Y., Li, J., & Lee, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4594 · Cited by 304
Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target
Vidyasagar, A., Wilson, N. A., & Djamali, A. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-7 · Cited by 296
Liu, T., Daniels, C. K., & Cao, S. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.014 · Cited by 295
Self-citationHsp60 expression, new locations, functions, and perspectives for cancer diagnosis and therapy
Cappello, F., Conway de Macario, E., Marasà, L., Zummo, G., & Macario, A. J. L. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.6281 · Cited by 280
Therapeutic and diagnostic implications of Hsp90 activation
Kamal, A., Boehm, M. F., & Burrows, F. J. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.04.006 · Cited by 278
Wadhwa, R., Sugihara, T., Yoshida, A., Nomura, H., Reddel, R. R., Simpson, R. J., Maruta, H., & Kaul, S. C. (2000) · PubMed · Cited by 277
HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy
WANG, X., CHEN, M., ZHOU, J., & ZHANG, X. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2399 · Cited by 269
Structure and Functional Relationships of Hsp90
Prodromou, C., & Pearl, L. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481877 · Cited by 261
Kang, B. H., Plescia, J., Song, H. Y., Meli, M., Colombo, G., Beebe, K., Scroggins, B., Neckers, L., & Altieri, D. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37613 · Cited by 240
Yokota, S., Kitahara, M., & Nagata, K. (2000) · PubMed · Cited by 228
HSP90 inhibitors: current development and potential in cancer therapy
Sidera, K., & Patsavoudi, E. (2013) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/15748928113089990031 · Cited by 222
Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1
Chen, H.-W., Lee, J.-Y., Huang, J.-Y., Wang, C.-C., Chen, W.-J., Su, S.-F., Huang, C.-W., Ho, C.-C., Chen, J. J. W., Tsai, M.-F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6734 · Cited by 221
Cheung, K.-M. J., Matthews, T. P., James, K., Rowlands, M. G., Boxall, K. J., Sharp, S. Y., Maloney, A., Roe, S. M., Prodromou, C., Pearl, L. H., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.046 · Cited by 219
hsp110 Protects Heat-denatured Proteins and Confers Cellular Thermoresistance
Oh, H. J., Chen, X., & Subjeck, J. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31636 · Cited by 214
Xu, L., Chen, S., & Bergan, R. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209337 · Cited by 213
A Nucleotide-dependent Molecular Switch Controls ATP Binding at the C-terminal Domain of Hsp90
Söti, C., Rácz, A., & Csermely, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105568200 · Cited by 212
Okawa, Y., Hideshima, T., Steed, P., Vallet, S., Hall, S., Huang, K., Rice, J., Barabasz, A., Foley, B., Ikeda, H., et al. (2009) · Blood · doi:10.1182/blood-2008-04-151928 · Cited by 210
Marzo, V. (2014) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488980901140428100532 · Cited by 196
Shiota, M., Bishop, J. L., Nip, K. M., Zardan, A., Takeuchi, A., Cordonnier, T., Beraldi, E., Bazov, J., Fazli, L., Chi, K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3979 · Cited by 194
Heat Shock Protein 60 Regulation of the Mitochondrial Permeability Transition Pore in Tumor Cells
Ghosh, J. C., Siegelin, M. D., Dohi, T., & Altieri, D. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2225 · Cited by 193
Sti1 Is a Non-competitive Inhibitor of the Hsp90 ATPase
Richter, K., Muschler, P., Hainzl, O., Reinstein, J., & Buchner, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213094200 · Cited by 188
Yang, Z., Zhuang, L., Szatmary, P., Wen, L., Sun, H., Lu, Y., Xu, Q., & Chen, X. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.10735 · Cited by 187
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion
Tsutsumi, S., Scroggins, B., Koga, F., Lee, M.-J., Trepel, J., Felts, S., Carreras, C., & Neckers, L. (2008) · Oncogene · doi:10.1038/sj.onc.1210897 · Cited by 178
Leung, T. K., Rajendran, M. Y., Monfries, C., Hall, C., & Lim, L. (1990) · Biochemical Journal · doi:10.1042/bj2670125 · Cited by 171
Chen, J.-S., Coustan-Smith, E., Suzuki, T., Neale, G. A., Mihara, K., Pui, C.-H., & Campana, D. (2001) · Blood · doi:10.1182/blood.v97.7.2115 · Cited by 170
Yi, X., Luk, J. M., Lee, N. P., Peng, J., Leng, X., Guan, X.-Y., Lau, G. K., Beretta, L., & Fan, S.-T. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700116-mcp200 · Cited by 169
Dorard, C., de Thonel, A., Collura, A., Marisa, L., Svrcek, M., Lagrange, A., Jego, G., Wanherdrick, K., Joly, A. L., Buhard, O., et al. (2011) · Nature Medicine · doi:10.1038/nm.2457 · Cited by 167
Brandt, G. E. L., Schmidt, M. D., Prisinzano, T. E., & Blagg, B. S. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8007486 · Cited by 166
Campanella, C., Rappa, F., Sciumè, C., Marino Gammazza, A., Barone, R., Bucchieri, F., David, S., Curcurù, G., Caruso Bavisotto, C., Pitruzzella, A., et al. (2015) · Cancer · doi:10.1002/cncr.29499 · Cited by 164
Hsp90 Activation and Cell Cycle Regulation
Burrows, F., Zhang, H., & Kamal, A. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1277 · Cited by 160
The Chaperoning Activity of hsp110
Oh, H. J., Easton, D. P., Murawski, M., Kaneko, Y., & Subjeck, J. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15712 · Cited by 159
Molecular chaperones: Multiple functions, pathologies, and potential applications
Alberto J., L. M. (2006) · Frontiers in bioscience · doi:10.2741/2257 · Cited by 156
Analogues of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, As Anti-Cancer Agents
Li, X., Srinivasan, S. R., Connarn, J. N., Ahmad, A., Young, Z. T., Kabza, A. M., Zuiderweg, E. R. P., Sun, D., & Gestwicki, J. E. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400204n · Cited by 154
Ohkubo, S., Kodama, Y., Muraoka, H., Hitotsumachi, H., Yoshimura, C., Kitade, M., Hashimoto, A., Ito, K., Gomori, A., Takahashi, K., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0219 · Cited by 148
Rajan, A., Kelly, R. J., Trepel, J. B., Kim, Y. S., Alarcon, S. V., Kummar, S., Gutierrez, M. E., Crandon, S. K., Zein, W. M., Jain, L., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0821 · Cited by 146
de La Motte Rouge, T., Galluzzi, L., Olaussen, K. A., Zermati, Y., Tasdemir, E., Robert, T., Ripoche, H., Lazar, V., Dessen, P., Harper, F., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0538 · Cited by 141
Thomas, X., Campos, L., Mounier, C., Cornillon, J., Flandrin‐Gresta, P., Le, Q., Piselli, S., & Guyotat, D. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.02.010 · Cited by 138
Hsp27 Modulates p53 Signaling and Suppresses Cellular Senescence
O’Callaghan-Sunol, C., Gabai, V. L., & Sherman, M. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2441 · Cited by 136
Roller, C., & Maddalo, D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00010 · Cited by 134
Johnson, M. L., Yu, H. A., Hart, E. M., Weitner, B. B., RADEMAKER, A. W., Patel, J. D., Kris, M. G., & Riely, G. J. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7328 · Cited by 131
Cytosolic Hsp60 Is Involved in the NF-κB-Dependent Survival of Cancer Cells via IKK Regulation
Chun, J. N., Choi, B., Lee, K. W., Lee, D. J., Kang, D. H., Lee, S. Y., Song, I. S., Kim, H. I., Lee, S. H., Kim, H. S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009422 · Cited by 127
HSP90 as a marker of progression in melanoma
McCarthy, M. M., Pick, E., Kluger, Y., Gould-Rothberg, B., Lazova, R. Z., Camp, R. L., Rimm, D. L., & Kluger, H. M. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm545 · Cited by 127
Abisambra, J. F., Blair, L. J., Hill, S. E., Jones, J. R., Kraft, C., Rogers, J. T., Koren, J., Jinwal, U. K., Lawson, L. Y., Johnson, A. G., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3155-10.2010 · Cited by 125
Interaction between HSP60 and β-catenin promotes metastasis
Tsai, Y., Yang, M., Huang, C.-H., Chang, S., Chen, P., Liu, C., Teng, S., & Wu, K.-J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp087 · Cited by 125
Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications
Zuo, D., Subjeck, J. R., & Wang, X. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00075 · Cited by 124
ATP and ADP Modulate a Cation Channel Formed by Hsc70 in Acidic Phospholipid Membranes
Arispe, N. J., & Maio, A. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005226200 · Cited by 122
Sims, J. T., Ganguly, S. S., Bennett, H., Friend, J. W., Tepe, J., & Plattner, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055509 · Cited by 121
HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem–like Cells
Nishizawa, S., Hirohashi, Y., Torigoe, T., Takahashi, A., Tamura, Y., Mori, T., Kanaseki, T., Kamiguchi, K., Asanuma, H., Morita, R., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3062 · Cited by 121
Tsai, M.-F., Wang, C.-C., Chang, G., Chen, C., Chen, H., Cheng, C.-L., Yang, Y.-P., Wu, C.-Y., Shih, F.-Y., Liu, C.-C., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj229 · Cited by 120
Hsp70: Anti-apoptotic and Tumorigenic Protein
Rérole, A.-L., Jego, G., & Garrido, C. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-295-3_16 · Cited by 118
Ko, S., Kim, J., Na, D. C., Park, S., Park, S., Hyun, J. Y., Baek, K.-H., Kim, N. D., Kim, N.-K., Park, Y. N., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.02.004 · Cited by 118
HSP90 regulates cell survival via inositol hexakisphosphate kinase-2
Chakraborty, A., Koldobskiy, M. A., Sixt, K. M., Juluri, K. R., Mustafa, A. K., Snowman, A. M., van Rossum, D. B., Patterson, R. L., & Snyder, S. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711168105 · Cited by 118
Human DNAJ in cancer and stem cells
Sterrenberg, J. N., Blatch, G. L., & Edkins, A. L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.019 · Cited by 118
Trinklein, N. D., Chen, W. C., Kingston, R. E., & Myers, R. (2004) · Cell Stress and Chaperones · doi:10.1379/481.1 · Cited by 118
Heat Shock Protein Hsp72 Controls Oncogene-Induced Senescence Pathways in Cancer Cells
Gabai, V. L., Yaglom, J. A., Waldman, T. A., & Sherman, M. Y. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01041-08 · Cited by 118
CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
Bao, R., Lai, C.-J., Qu, H., Wang, D.-G., Yin, L., Zifcak, B. M., Atoyan, R., Wang, J., Samson, M., Forrester, J. S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0152 · Cited by 116
Wang, N., Wang, Z., Peng, C. Y., You, J., Shen, J., Han, S., & Chen, J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu187 · Cited by 116
Manjili, M. H., Wang, X., Chen, X., Martin, T. G., Repasky, E. A., Henderson, R. A., & Subjeck, J. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4054 · Cited by 115
Chen, S.-F., Nieh, S., Jao, S., Liu, C., Wu, C.-H., Chang, Y., Yang, C., & Lin, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049275 · Cited by 113
Roué, G., Pérez‐Galán, P., Mozos, A., López‐Guerra, M., Xargay‐Torrent, S., Rosich, L., Saborit-Villarroya, I., Normant, E., Campo, E., & Colomer, D. (2010) · Blood · doi:10.1182/blood-2010-04-278853 · Cited by 110
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer
Mitra, A., Fillmore, R. A., Metge, B. J., Rajesh, M. P., Xi, Y., King, J., Ju, J., Pannell, L. K., Shevde, L. A., & Samant, R. S. (2008) · Breast Cancer Research · doi:10.1186/bcr1874 · Cited by 110
Misra, U. K., Mowery, Y. M., Kaczowka, S. J., & Pizzo, S. V. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0990 · Cited by 109
Shi, Y., Liu, X., Lou, J., Han, X., Zhang, L., Wang, Q., Li, B., Dong, M., & Zhang, Y. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0174 · Cited by 109
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors
Dickson, M. A., Okuno, S. H., Keohan, M. L., Maki, R. G., D’Adamo, D. R., Akhurst, T., Antonescu, C. R., & Schwartz, G. K. (2012) · Annals of Oncology · doi:10.1093/annonc/mds275 · Cited by 108
Heinrich, J. C., Tuukkanen, A. T., Schroeder, M., Fahrig, T., & Fahrig, R. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1005-1 · Cited by 106
A Modified HSP70 Inhibitor Shows Broad Activity as an Anticancer Agent
Balaburski, G. M., Leu, J. I.-J., Beeharry, N., Hayik, S. A., Andrake, M., Zhang, G., Herlyn, M., Villanueva, J., Dunbrack, R. L., Yen, T. J., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0547-t · Cited by 106
Kang, B. H., Siegelin, M. D., Plescia, J., Raskett, C. M., Garlick, D. S., Dohi, T., Lian, J. B., Stein, G. S., Languino, L. R., & Altieri, D. C. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1818 · Cited by 105
Kim, J. A., Kim, Y., Kwon, B., & Han, D. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.488346 · Cited by 104
Nagaraju, G. P., Long, T., Park, W., Landry, J. C., Taliaferro-Smith, L. D., Farris, A. B., Diaz, R., & El‐Rayes, B. F. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22185 · Cited by 102
Lu, Z., Jin, Y., Qiu, L., Lai, Y., & Pan, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.006 · Cited by 101
Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60
Wadhwa, R., Takano, S., Kaur, K., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050861 · Cited by 100
Quercetin suppresses HeLa cell viability via AMPK‐induced HSP70 and EGFR down‐regulation
Jung, J. H., Lee, J. O., Kim, J. H., Lee, S. K., You, G. Y., Park, S. H., Park, J. M., Kim, E., Suh, P., An, J. K., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22049 · Cited by 99
Shelton, S. N., Shawgo, M. E., Matthews, S. B., Lu, Y., Donnelly, A. C., Szabla, K., Tanol, M., Vielhauer, G. A., Rajewski, R. A., Matts, R. L., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058545 · Cited by 99
Ferraldeschi, R., Welti, J. C., Powers, M. V., Yuan, W., Smyth, T., Seed, G., Riisnaes, R., Hedayat, S., Wang, H., Crespo, M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2186 · Cited by 98
KUBOTA, H. Y., Yamamoto, S., Itoh, E., Abe, Y., Nakamura, A., Izumi, Y., Okada, H., Iida, M., Nanjo, H., Itoh, H., et al. (2010) · Cell Stress and Chaperones · doi:10.1007/s12192-010-0211-0 · Cited by 93
Hamelin, C., Cornut, E., Poirier, F., Pons, S., Beaulieu, C., Charrier, J., Haïdous, H., Cotte, E., Lambert, C., Piard, F., et al. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08385.x · Cited by 91
Shapiro, G. I., Kwak, E. L., Dezube, B. J., Yule, M., Ayrton, J., Lyons, J. F., & Mahadevan, D. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0979 · Cited by 91
Kim, J. A., Lee, S., Kim, D., Kim, M., Kwon, B., & Han, D. C. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv045 · Cited by 91
Cripto/GRP78 modulation of the TGF‐β pathway in development and oncogenesis
Gray, P. C., & Vale, W. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.051 · Cited by 88
Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers
Gibert, B., Hadchity, É., Czekalla, A., Aloy, M.-T., Colas, P., Rodriguez‐Lafrasse, C., Arrigo, A., & Diaz‐Latoud, C. (2011) · Oncogene · doi:10.1038/onc.2011.73 · Cited by 87
Lin, Y., Wang, Z., Liu, L., & Chen, L. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.06.004 · Cited by 87
Starenki, D., Hong, S.-K., Lloyd, R. V., & Park, J.-I. (2014) · Oncogene · doi:10.1038/onc.2014.392 · Cited by 87
Wagner, A. J., Chugh, R. K., Rosen, L. S., Morgan, J. A., George, S., Gordon, M. S., Dunbar, J., Normant, E., Grayzel, D., & Demetri, G. D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0953 · Cited by 85
Discovery of XL888: A novel tropane-derived small molecule inhibitor of HSP90
Bussenius, J., Blazey, C. M., Aay, N., Anand, N. K., Arcalas, A., Baik, T., Bowles, O. J., Buhr, C. A., Costanzo, S., Curtis, J. K., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.052 · Cited by 84
Immune Mechanism of the Antitumor Effects Generated by Bortezomib
Chang, C.-L., Hsu, Y.-T., Wu, C.-C., Yang, Y., Wang, C., Wu, T.-Q., & Hung, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103826 · Cited by 84
Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells
Jiang, C. C., Mao, Z. G., Avery‐Kiejda, K. A., Wade, M., Hersey, P., & Zhang, X. D. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn220 · Cited by 83
The novel HSP90 inhibitor STA‐1474 exhibits biologic activity against osteosarcoma cell lines
McCleese, J., Bear, M. D., Fossey, S. L., Mihalek, R., Foley, K. P., Ying, W., Barsoum, J., & London, C. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24660 · Cited by 83
Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer
Isomoto, H., Oka, M., Yano, Y., Kanazawa, Y., Soda, H., Terada, R., Yasutake, T., Nakayama, T., Shikuwa, S., Takeshima, F., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00305-7 · Cited by 83
Wang, C.-C., Tsai, M.-F., Hong, T.-M., Chang, G., Chen, C., Yang, W., Chen, J. J. W., & Yang, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208573 · Cited by 82
Cooperation of heat shock protein 90 and p23 in aryl hydrocarbon receptor signaling
Cox, M. B., & Miller, C. A. (2004) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2004)009<0021:traboh>2.0.co;2 · Cited by 81
Lin, S.-P., Lee, Y., Wang, J.-Y., Miller, S. A., Chiou, S., Hung, M., & Hung, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049605 · Cited by 80
Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia
Kaiser, M., Kühnl, A., Reins, J., Fischer, S., Ortiz-Tánchez, J., Schlee, C., Mochmann, L. H., Heesch, S., Benlasfer, O., Hofmann, W.-K., et al. (2011) · Blood Cancer Journal · doi:10.1038/bcj.2011.28 · Cited by 78
Chiou, J., Tai, C.-J., Huang, M., Wei, P., Wang, Y.-H., An, J., Wu, C., Liu, T., & Chang, Y. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0718-8 · Cited by 78
Self-citationThe potential role of heat shock protein 27 in cardiovascular disease
Ghayour‐Mobarhan, M., Saber, H., & Ferns, G. A. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.005 · Cited by 77
Seggewiß-Bernhardt, R., Bargou, R. C., Goh, Y. T., Stewart, A. K., Spencer, A. G., Alegre, A. M., Bladé, J., Ottmann, O. G., Fernandez‐Ibarra, C., Lu, H. L., et al. (2015) · Cancer · doi:10.1002/cncr.29339 · Cited by 75
Huang, W., Ye, M., Zhang, L., Wu, Q.-D., Zhang, M., Xu, J., & Zheng, W. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-150 · Cited by 74
Georgakis, G. V., Li, Y., & Younes, A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06247.x · Cited by 73
Misra, U. K., Payne, S., & Pizzo, S. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129767 · Cited by 73
Lu, W., Lee, N. P. Y., Kaul, S. C., Lan, F., Poon, R. T. P., Wadhwa, R., & Luk, J. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25857 · Cited by 72
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
He, S., Smith, D. L., Sequeira, M., Sang, J., Bates, R. C., & Proia, D. A. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0095-4 · Cited by 72
Trinh, D. L. N., Elwi, A. N., & Kim, S.-W. (2010) · Oncotarget · doi:10.18632/oncotarget.174 · Cited by 69
Mahoney, S. E., Yao, Z., Keyes, C. C., Tapscott, S. J., & Diede, S. J. (2012) · Epigenetics · doi:10.4161/epi.19463 · Cited by 69
The Benzoquinone Ansamycin Geldanamycin Stimulates Proteolytic Degradation of Focal Adhesion Kinase
Ochel, H.-J., Schulte, T. W., Nguyen, P., Trepel, J. B., & Neckers, L. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2774 · Cited by 69
Expression of Heat Shock Protein 60 kDa Is Upregulated in Cervical Cancer
Hwang, Y. J., Lee, S. P., Kim, S. Y., Choi, Y. H., Kim, M., Lee, C. H., Lee, J. Y., & Kim, D. Y. (2009) · Yonsei Medical Journal · doi:10.3349/ymj.2009.50.3.399 · Cited by 69
Proia, D. A., Zhang, C., Sequeira, M., Jimenez, J.-P., He, S., Spector, N. L., Shapiro, G. I., Tolaney, S. M., Nagai, M., Acquaviva, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2166 · Cited by 69
Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells
Nomura, M., Nomura, N., Newcomb, E. W., Lukyanov, Y., Tamasdan, C., & Zagzag, D. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20090 · Cited by 68
Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1
Wen, K. W., & Damania, B. (2010) · Oncogene · doi:10.1038/onc.2010.124 · Cited by 67
杉田, 翔., Ito, K., Yamashiro, Y., Moriya, S., Che, X., Yokoyama, T., Hiramoto, M., & Miyazawa, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.162 · Cited by 67
Moses, M. A., Henry, E. C., Ricke, W. A., & Gasiewicz, T. A. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0224 · Cited by 67
Moon, J., & Cho, S. K. (2016) · Molecules · doi:10.3390/molecules21070914 · Cited by 67
DNAJB6 Induces Degradation of β-Catenin and Causes Partial Reversal of Mesenchymal Phenotype
Mitra, A., Menezes, M. E., Shevde, L. A., & Samant, R. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094847 · Cited by 66
HSP70 Protein Promotes Survival of C6 and U87 Glioma Cells by Inhibition of ATF5 Degradation
Li, G., Xu, Y., Guan, D., Liu, Z., & Liu, D. X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211771 · Cited by 66
Role of hsp105 in Protection against Stress-Induced Apoptosis in Neuronal PC12 Cells
Hatayama, T., Yamagishi, N., Minobe, E., & Sakai, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5802 · Cited by 65
Chan, K. C., Ting, C. M., Chan, P. S., Lo, M. C., Lo, K. W., Curry, J. E., Smyth, T., Lee, A. W. M., Ng, W. T., Tsao, G. S., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-128 · Cited by 64
HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression
Wilkerson, D. C., Skaggs, H. S., & Sarge, K. D. (2007) · Cell Stress and Chaperones · doi:10.1379/csc-250.1 · Cited by 63
Rozenberg, P., Kocsis, J., Saar, M., Prohászka, Z., Füst, G., & Fishelson, Z. (2013) · International Journal of Cancer · doi:10.1002/ijc.28029 · Cited by 62
Górska‐Ponikowska, M., Marino, A., Zmijewski, M. A., Campanella, C., Cappello, F., Wasiewicz, T., Kuban‐Jankowska, A., Daca, A., Sielicka, A., Popowska, U., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071135 · Cited by 62
Koga, F., Tsutsumi, S., & Neckers, L. Μ. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4296 · Cited by 62
Roberts, J. L., Tavallai, M., Nourbakhsh, A., Fidanza, A., Cruz‐Luna, T., Smith, E., Siembida, P., Plamondon, P., Cycon, K. A., Doern, C. D., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25014 · Cited by 61
Wong, S. C. C., Wong, V. H., Chan, C. M. L., Ma, B. B. Y., Hui, E. P., Wong, M. C. K., Lam, M. Y. Y., Au, T. C. C., Chan, W.-H., Cheuk, W., et al. (2008) · Oncology Reports · doi:10.3892/or.20.1.89 · Cited by 61
Kang, S.-M., Kim, S.-J., Kim, J. H., Lee, W., Kim, G., Lee, K.-H., Choi, K., & Oh, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.003 · Cited by 60
Wang, C., Liao, Y., Mischel, P. S., Iwamoto, K. S., Cacalano, N. A., & McBride, W. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0185 · Cited by 60
Hung, C.-M., Su, Y., Lin, H.-Y., Lin, J.-N., Liu, L.-C., Ho, C.-T., & Way, T.-D. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf302754w · Cited by 60
Smith, K. J., Twal, W. O., Soodavar, F., Virella, G., Lopes-Virella, M. F., & Hammad, S. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.113605 · Cited by 58
Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice
Chen, T. H.-P., Kambal, A., Krysiak, K., Walshauser, M. A., Raju, G., Tibbitts, J. F., & Walter, M. J. (2010) · Blood · doi:10.1182/blood-2010-06-293167 · Cited by 58
Rationally Repurposing Ruxolitinib (Jakafi®) as a Solid Tumor Therapeutic
Tavallai, M., Booth, L. A., Roberts, J. L., Poklepovic, A. S., & Dent, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00142 · Cited by 58
Mortalin is a prognostic factor of gastric cancer with normal p53 function
Ando, K., Oki, E., Zhao, Y., Ikawa‐Yoshida, A., Kitao, H., Saeki, H., Kimura, Y., Ida, S., Morita, M., Kusumoto, T., et al. (2013) · Gastric Cancer · doi:10.1007/s10120-013-0279-1 · Cited by 57
Proteomic investigation of anti‐tumor activities exerted by sinularin against A 2058 melanoma cells
Su, T., Lin, J., Chiu, C., Chen, J. Y., Su, J., Cheng, Z., Hwang, W., Huang, H. H., & Wu, Y. (2012) · Electrophoresis · doi:10.1002/elps.201100462 · Cited by 56
FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70
Wang, Y., Wang, S., Zhang, X., Zhao, M., Hou, C., Xu, Y.-J., Du, Z., & Yu, X. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.076 · Cited by 56
Sekihara, K., Harashima, N., Tongu, M., Tamaki, Y., Uchida, N., Inomata, T., & Harada, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078772 · Cited by 56
Ullmann, R., Morbini, P., Halbwedl, I., Bongiovanni, M., Gogg-Kamerer, M., Papotti, M. G., Gabor, S., Renner, H., & Popper, H. (2004) · The Journal of Pathology · doi:10.1002/path.1584 · Cited by 56
Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells.
Kuramitsu, Y., Wang, Y., Taba, K., et al. (2012) · PubMed · Cited by 55
Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma
Chen, C., Chiou, S., Huang, C., Jan, C., Lin, S., Hu, W., Chou, S., Liu, C., & Lo, J. (2009) · The Journal of Pathology · doi:10.1002/path.2604 · Cited by 55
Lee, D.-H., Sung, K. S., Bartlett, D. L., Kwon, Y. T., & Lee, Y. J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.013 · Cited by 54
Castle, P. E., Ashfaq, R., Ansari, F., & Muller, C. Y. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.06.045 · Cited by 53
DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis
Cui, X., Choi, H., Choi, Y.-S., Park, S., Sung, G., Lee, Y., Lee, J., Jun, W. J., Kim, K., Choi, K., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.041 · Cited by 52
Do, K. T., Speranza, G., Chang, L., Polley, E. C., Bishop, R. J., Zhu, W., Trepel, J. B., Lee, S., Lee, M.-J., Kinders, R. J., et al. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0255-1 · Cited by 51
Floris, G., Sciot, R., Woźniak, A., Looy, T. V., Wellens, J., Faa, G., Normant, E., Dêbiec‐Rychter, M., & Schöffski, P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0562 · Cited by 51
The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60
Chaiwatanasirikul, K.-A., & Sala, A. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.99 · Cited by 51
Kimura, A., Ogata, K., Altan, B., Yokobori, T., Ide, M., Mochiki, E., Toyomasu, Y., Kogure, N., Yanoma, T., Suzuki, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7821 · Cited by 51
Wang, X., Zhang, Y., Zhao, Y., Liang, Y., Xiang, C., Zhou, H., Zhang, H., Zhang, Q., Qing, H., Jiang, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10971 · Cited by 51
Wang, X., Sun, X., Chen, X., Facciponte, J. G., Repasky, E. A., Kane, J. M., & Subjeck, J. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903891 · Cited by 50
Wang, X., & Subjeck, J. R. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.803607 · Cited by 50
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target
Zappasodi, R., Bongarzone, I., Ghedini, G. C., Castagnoli, L., Cabras, A. D., Messina, A., Tortoreto, M., Tripodo, C., Magni, M., Carlo‐Stella, C., et al. (2011) · Blood · doi:10.1182/blood-2011-06-364570 · Cited by 49
Kim, S.-W., Hayashi, M., Lo, J., Fearns, C., Xiang, R., Lazennec, G., Yang, Y. C., & Lee, J.-D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4422 · Cited by 49
High expression of heat shock protein 90 alpha and its significance in human acute leukemia cells
Tian, W., He, F., Fu, X., Lin, J., Tang, P., Huang, Y., Guo, R., & Sun, L. (2014) · Gene · doi:10.1016/j.gene.2014.03.046 · Cited by 48
Peptide aptamers: tools to negatively or positively modulate HSPB1(27) function
Gibert, B., Simon, S., Dimitrova, V., Diaz‐Latoud, C., & Arrigo, A. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0075 · Cited by 48
DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity
Menezes, M. E., Mitra, A., Shevde, L. A., & Samant, R. S. (2012) · Biochemical Journal · doi:10.1042/bj20120205 · Cited by 47
Chakravarty, G., Mathur, A., Mallade, P., Gerlach, S. L., Willis, J., Datta, A., Srivastav, S., Abdel‐Mageed, A. B., & Mondal, D. (2016) · Biochimie · doi:10.1016/j.biochi.2016.01.014 · Cited by 47
Expression of Heat Shock Protein (Hsp) 70 and Hsp 40 in Colorectal Cancer
Kanazawa, Y., Isomoto, H., Oka, M., Yano, Y., Soda, H., Shikuwa, S., Takeshima, F., Omagari, K., Mizuta, Y., Murase, K., et al. (2003) · Medical Oncology · doi:10.1385/mo:20:2:157 · Cited by 46
Yang, L., Li, H., Jiang, Y., Zuo, J., & Liu, W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.004 · Cited by 45
Gestl, E. E., & Böttger, S. A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.139 · Cited by 45
Stabilization of integrin-linked kinase by binding to Hsp90
Aoyagi, Y., Fujita, N., & Tsuruo, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.225 · Cited by 45
IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma
Kolosenko, I., Grandér, D., & Tamm, K. P. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140414100831 · Cited by 45
Membrane HSP70: The Molecule Triggering γδ T Cells in the Early Stage of Tumorigenesis
Zhang, H., Hu, H., Jiang, X., He, H., Cui, L., & He, W. (2005) · Immunological Investigations · doi:10.1080/08820130500265349 · Cited by 44
Hsp90 — a potential prognostic marker in CML
Žáčková, M., Moučková, D., Lopotová, T., Ondráčková, Z., Klamová, H., & Moravcová, J. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.11.002 · Cited by 44
Bae, M., Jeong, J., Kim, S., Kim, S. Y., Kang, H. J., Kim, D., Bae, S., Yun, I., Trentin, G. A., Rozakis-Adcock, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-2735 · Cited by 44
Reddy, N. M., Voorhees, P. M., Houk, B. E., Brega, N. M., Hinson, J. M., & Jillela, A. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.03.010 · Cited by 43
Direct regulation of HSP60 expression by c‐MYC induces transformation
Tsai, Y., Teng, S., & Wu, K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.11.004 · Cited by 42
Wei, Q., White, M. C., Choi, W., Guo, C. C., Dinney, C. P., McConkey, D. J., & Siefker-Radtke, A. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069509 · Cited by 41
Hsc70 Contributes to Cancer Cell Survival by Preventing Rab1A Degradation under Stress Conditions
Tanaka, M., Mun, S., Harada, A., Ohkawa, Y., Inagaki, A., Sano, S., Takahashi, K., Izumi, Y., Osada‐Oka, M., Wanibuchi, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096785 · Cited by 40
Novel peptides secreted from human neuroblastoma: useful clinical tools?
Sandoval, J. A., Hoelz, D. J., Woodruff, H. A., Powell, R. L., Jay, C. L., Grosfeld, J. L., HickeyD, R. J., & Malkas, L. H. (2006) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2005.10.048 · Cited by 40
OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro
Arafa, E. A., Abdelazeem, A. H., Arab, H. H., & Omar, H. A. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.183 · Cited by 40
Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK – ERK pathway
Hu, Y., Yang, L., Yang, Y., Han, Y., Wang, Y., Liu, W., & Zuo, J. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12905 · Cited by 40
DNAJB1 negatively regulates MIG6 to promote epidermal growth factor receptor signaling
Park, S., Choi, H.-K., Seo, J. S., Yoo, J., Jeong, J., Choi, Y., Choi, K., & Yoon, H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.07.024 · Cited by 39
Fu, W.-M., Zhang, J.-F., Wang, H., Xi, Z., Wang, W.-M., Zhuang, P., Zhu, X. M., Chen, S., Chan, T.-M., Leung, K., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.05.032 · Cited by 39
Yu, L., Yuan, X., Wang, D., Barakat, B., Williams, E. D., & Hannigan, G. E. (2013) · Oncogene · doi:10.1038/onc.2013.20 · Cited by 38
Kim, J. H., Kim, K.-J., Rhee, Y.-Y., Oh, S., Cho, N., Lee, H. S., & Kang, G. H. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.160 · Cited by 38
Zhu, H., Woolfenden, S., Bronson, R. T., Jaffer, Z. M., Barluenga, S., Winssinger, N., Rubenstein, A. E., Chen, R., & Charest, A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0248 · Cited by 38
Hsp90 inhibition enhances PI-3 kinase inhibition and radiosensitivity in glioblastoma
Wachsberger, P. R., Lawrence, Y. R., Liu, Y., Rice, B., Feo, N., Leiby, B. E., & Dicker, A. P. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1594-6 · Cited by 38
Wang, J., Li, Z., Lin, Z., Zhao, B., Wang, Y., Peng, R., Wang, M., Lu, C., Shi, G., & Shen, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.025 · Cited by 38
Ramp, U., Mahotka, C., Heikaus, S., Shibata, T., Grimm, M., Willers, R., & Gabbert, H. E. (2007) · PubMed · doi:10.14670/hh-22.1099 · Cited by 38
Huang, T.-Y., Chen, S., Han, H., Li, H., Huang, Z., Zhang, J., Yin, Q., Wang, X., Ma, X., Dai, P., et al. (2014) · Europe PMC (PubMed Central) · Cited by 37
HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma
Ruan, W., Wang, Y., Ma, Y., Xing, X., Lin, J., Cui, J., & Lai, M. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-41 · Cited by 36
Yang, T., Li, X., Li, X.-G., Li, M., & Gao, P.-Z. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.011 · Cited by 35
Yerushalmi, R., Raiter, A., Nalbandyan, K., & Hardy, B. (2015) · Oncology Letters · doi:10.3892/ol.2015.3579 · Cited by 35
Cited by
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Recent advances in therapeutic strategies for triple-negative breast cancer
Li, Y., Zhang, H., Merkher, Y., Chen, L., Liu, N., Leonov, S., & Chen, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01341-0 · Cited by 956
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
Chatterjee, S., & Burns, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091978 · Cited by 501
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Liu, Y., Zhou, F., Ali, H., Lathia, J. D., & Chen, P. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01226-x · Cited by 336
The post-translational modification, SUMOylation, and cancer (Review)
Han, Z.-J., Feng, Y.-H., Gu, B.-H., Li, Y.-M., & Chen, H. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4280 · Cited by 334
Metadata
- Authors
- Wu, J., Liu, T., Rios, Z., Mei, Q., Lin, X., & Cao, S.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 38
- Issue
- 3
- Pages
- 226-256
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2566859523
- Cited by
- 696
- References
- 250
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.